The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity ...

A pill from Structure Therapeutics Inc. helped patients lose roughly as much weight as a rival treatment from Eli Lilly & Co.

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...

A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

Soybean oil, used for cooking in more than half of American households, is linked to a higher risk of obesity in a new study.

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

A study found soybean oil contributed to obesity in mice, prompting concern about its use as America's most popular cooking ...

The researchers assessed the association between Alzheimer’s biomarkers and body mass index (BMI), according to a press ...

Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...